d******8
发帖数: 1972 | 1 Horizon Pharma - "Horizon Pharma, Inc., a biopharmaceutical company, through
its subsidiaries, develops and commercializes medicines for the treatment
of arthritis, pain, and inflammatory diseases". (Business Description from
Yahoo Finance)
4 additional reasons HZNP makes sense as a high risk/high reward biotech
play at under $4 a share:
Insiders have bought over 10mm shares over the last year, much of it at
significantly higher prices.
Revenues are set to explode. The company had under $7mm in sales in FY2011.
Analysts expect over $30mm in revenue in FY2012 and over $90mm in FY2013.
Only two firms cover the stock (Stifel Nicolaus and JMP Securities). However
, they both have outperform or accumulate ratings on the stock. In addition,
price targets are $10 and $16 a share on HZNP by these firms.
The company has plenty of net cash on its balance sheet, seems to have no
problem raising debt or equity and given its small market capitalization (
under $100mm after net cash) and exponentially increasing revenues; it would
be a logical acquisition target. | w****s
发帖数: 47 | 2 你发了，涨30%了，牛！
through
.
【在 d******8 的大作中提到】
: Horizon Pharma - "Horizon Pharma, Inc., a biopharmaceutical company, through
: its subsidiaries, develops and commercializes medicines for the treatment
: of arthritis, pain, and inflammatory diseases". (Business Description from
: Yahoo Finance)
: 4 additional reasons HZNP makes sense as a high risk/high reward biotech
: play at under $4 a share:
: Insiders have bought over 10mm shares over the last year, much of it at
: significantly higher prices.
: Revenues are set to explode. The company had under $7mm in sales in FY2011.
: Analysts expect over $30mm in revenue in FY2012 and over $90mm in FY2013.
|
|
